Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR NewswireDec 18 05:15

Needham Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Cuts Target Price to $195

Futu NewsDec 18 03:32 · Ratings

TD Cowen Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $195

Futu NewsDec 17 20:33 · Ratings

Jazz Pharmaceuticals (JAZZ) Gets a Buy From TD Cowen

TipRanksDec 17 20:15 · Ratings

Jazz Pharmaceuticals Announces CEO Succession Plan; Bruce Cozadd, Co-Founder, Chairperson And CEO, Plans To Retire As CEO Upon Appointment Of Successor By The End Of 2025; Will Continue As Chair Of The Board; Jazz Remains On Track To Meet Its FY24...

BenzingaDec 17 05:07

Express News | Jazz Pharmaceuticals PLC - Bruce Cozadd to Retire as CEO by End of 2025

BreakingsDec 17 05:05